AbbVie Inc. (ABBV) Earnings: Quarterly Revenue, EPS and Margins
How are revenue and profit of AbbVie Inc. developing? This page lists revenue, operating income, net income and earnings per share by quarter, taken from the company's published reports.
AbbVie Inc. latest annual figures (FY 2025)
In the latest reported fiscal year (FY 2025), AbbVie Inc. generated revenue of 61.16 USD bn. The largest segment is Immunology with 30.41 USD bn, about 49.7 % of total segment revenue. From gross margin (70.2 %) through operating margin (24.6 %) to net margin (6.9 %), the Sankey diagram shows how much of each revenue dollar remains at each stage of the income statement.
AbbVie Inc. revenue by segment (FY 2025)
| Segment | Revenue | Share |
|---|---|---|
| Immunology | 30.41 USD bn | 49.7 % |
| Neuroscience | 10.77 USD bn | 17.6 % |
| Oncology | 6.66 USD bn | 10.9 % |
| Aesthetics | 4.86 USD bn | 7.9 % |
| Eye Care | 2.11 USD bn | 3.4 % |
| Other Key Products | 3.74 USD bn | 6.1 % |
| All Other | 2.63 USD bn | 4.3 % |
Frequently asked questions about AbbVie Inc.
When does AbbVie Inc. report earnings?
AbbVie Inc. publishes quarterly results four times a year. The quarters listed on this page follow the company's fiscal calendar as reported in its filings.
What was AbbVie Inc. revenue in the last fiscal year?
AbbVie Inc. reported revenue of 61.16 USD bn (FY 2025).
How profitable is AbbVie Inc.?
Net margin was 6.9 % (FY 2025), meaning that share of every revenue unit remained as profit.